Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07633743Recruiting
Virtual Reality for Managing Menopause Hot Flashes
This study tests whether using a virtual-reality headset at home can help reduce hot flashes and night sweats in midlife women. You would use the VR system weekly for 8 weeks to see if it improves your symptoms.
Jacksonville, FloridaAges 45–60 - NCT07632820RecruitingPhase 4
Nerve Block vs. Injection for Upper Back Muscle Pain
This study compares two ways to treat chronic muscle pain in the upper back: a nerve block (numbing injection near the spine) and trigger point injections (shots directly into painful muscle knots). The goal is to see which approach works better for long-lasting relief.
Jacksonville, FloridaAges 18–80 - NCT07636876Enrolling by invitation
Italian MS and Related Disorders Patient Registry
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
Genova, GenovaAges Any age - NCT07637227Recruiting
Comparing two types of clear aligners for teeth straightening
This study tests two different ways of making clear aligners (custom plastic trays that move your teeth). Researchers want to see if 3D-printed aligners work as well as traditional heat-formed ones for mild crowding or spacing.
Baghdad, Bab Al-MuadhamAges 15–30 - NCT07634549RecruitingPhase 4
Plant-based albumin for low blood protein after liver surgery
This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.
Wuhan, HubeiAges 18–80 - NCT07634575Enrolling by invitation
Smart imaging for newly diagnosed brain cancer
This study tests whether imaging scans can be timed based on your symptoms and progress, rather than on a fixed schedule. The goal is to make monitoring easier while keeping you safe during standard brain cancer treatment.
LondonAges 18 years+ - NCT06452706RecruitingPhase 2
Study of TQB2102 for HER2-negative breast cancer that has spread
This study tests a new drug, TQB2102, for people with HER2-negative breast cancer that has spread and no longer responds to standard treatments. The goal is to see if the drug can shrink tumors or slow the cancer.
Bozhou, AnhuiAges 18–75 - NCT06632262RecruitingPhase 2
Testing new drugs for cancers with FGFR gene changes
This trial tests two new drugs, ABSK061 and ABSK043, in people whose cancers have specific changes in the FGFR2 or FGFR3 genes. It may be an option if your cancer has stopped responding to standard treatments or if no standard treatment is available.
Guiyang, GuizhouAges 18 years+ - NCT06517927Recruiting
Long-term dental effects of childhood cancer chemo
This study looks at how chemotherapy given before age 10 affects teeth later in life. Researchers want to know if childhood cancer survivors have more dental problems than others.
BrusselsAges 12–36 - NCT06576284Recruiting
Tracking custom dental implant performance over 3 years
This study follows people who already received a personalized dental implant designed by computer. Researchers want to see how the implant performs over 3 years, measuring things like how well it works and if any problems come up.
São PauloAges Any age - NCT06693973RecruitingEarly Phase 1
AcNK-Sup003 cell therapy for relapsed B-cell lymphoma
This early-phase trial tests a new immune cell treatment called AcNK-Sup003 for people with B-cell non-Hodgkin's lymphoma that has come back or not responded to prior therapy. The goal is to see if it is safe and effective.
Wuhan, HubeiAges 18 years+ - NCT06695689RecruitingEarly Phase 1
LM303 injection for advanced solid tumors
This trial tests an investigational treatment called LM303 for people with advanced solid tumors like melanoma, lung cancer, or cervical cancer. It uses your own immune cells (called TILs) to fight the cancer, so you need a tumor large enough for cells to be collected.
TianjinAges 18 years+ - NCT06566586RecruitingPhase 2
Study of TQB3702 plus immunochemotherapy for B-cell lymphoma
This trial tests a new tablet (TQB3702) combined with standard immune-and-chemo therapy for certain types of B-cell lymphoma that have come back or not responded to previous treatment. It aims to see if the combination is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT07623616RecruitingPhase 2
Ziftomenib for relapsed AML with NPM1 mutation
This trial tests a new drug called ziftomenib in patients whose acute myeloid leukemia (AML) has come back or stopped responding to treatment and has a specific genetic change called an NPM1 mutation. The drug targets a protein called menin that may help cancer cells grow, and researchers hope it could help patients who have run out of standard treatment options.
ChibaAges 18 years+ - NCT07623564Enrolling by invitation
Breast Surgery Study Using Minimally Invasive Techniques
This study examines how well breast tissue is preserved during cosmetic breast augmentation or reconstruction using new minimally invasive surgical methods. If you're having one of these procedures, this research may help doctors better understand how to maintain healthy breast tissue and improve surgical outcomes.
Coyol, Alajuela ProvinceAges 18 years+ - NCT07620938RecruitingPhase 2
TJ0113 capsule for treating muscle loss in older adults
This study tests a new capsule called TJ0113 to see if it can help older adults with sarcopenia (muscle loss) improve their muscle strength and physical function. It's a phase 2 study, meaning the drug is being tested for safety and effectiveness.
Hangzhou, ZhejiangAges 60 years+ - NCT07624500Recruiting
How Different Foods Affect Your Metabolism and Blood Sugar
This study tests how specific foods impact your body's ability to manage blood sugar and fat levels. You'll eat meals provided by the research team for about 12 weeks to help researchers understand which foods work best for people with high triglycerides (a type of blood fat) and insulin resistance (difficulty managing blood sugar).
Chicago, IllinoisAges 40–70 - NCT06697938Recruiting
Chemo plus radiation vs. chemo alone for locally advanced breast cancer
This trial compares two treatments for locally advanced breast cancer: chemotherapy before surgery plus radiation, versus chemotherapy before surgery alone. The goal is to see which approach works better for this specific type of cancer.
Chengdu, SichuanAges 18–70 - NCT07622771RecruitingPhase 2
Radiation, chemotherapy, and immunotherapy for advanced rectal cancer
This trial tests a combination of radiation therapy, a chemotherapy drug called NALIRIFOX, and an immunotherapy drug called adebrelimab for rectal cancer that has grown into nearby tissue or lymph nodes. The goal is to see if this combination helps shrink the tumor before surgery and improves outcomes.
Guangzhou, GuangdongAges 18–75 - NCT07629349Recruiting
Understanding Lewy Body Dementia Symptoms and Progression
This study follows people with dementia with Lewy bodies to understand how the disease develops and changes over time. Researchers will track your symptoms and use blood tests and brain imaging to learn more about what causes this type of dementia.
StockholmAges Any age - NCT07622498Recruiting
Testing a new blood pressure device accuracy
This trial compares a new blood pressure monitor (HiCardi M350) to the traditional manual method to see if it's accurate. You'll visit the hospital a few times to have your blood pressure measured with both devices.
Seoul, SeoulAges 19 years+ - NCT07622797RecruitingPhase 2
Immunotherapy with chemotherapy and radiation for esophageal cancer
This trial tests a new immunotherapy drug (camrelizumab) combined with standard chemotherapy and radiation to treat advanced esophageal cancer while avoiding surgery if possible. The goal is to shrink the tumor and help you keep your esophagus working.
Luoyang, HenanAges 18 years+ - NCT07627334Recruiting
Personalized drug testing for newly diagnosed brain tumors
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
Vienna, State of ViennaAges Any age - NCT07624786Recruiting
Study of How Breathing Tubes and Patients Work Together
This study looks at recordings from patients on breathing machines (ventilators) in the hospital to understand when the machine and patient's breathing don't sync up, and whether this affects how well patients do. Researchers will review your medical records and machine data that were already collected during your hospital stay.
Eindhoven, North BrabantAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.